Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadashi Nishimura

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Thoracic Cancer|February 15, 2021
Second-line therapy with first- or second-generation tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer patients with T790M-negative or unidentified mutationTadashi Nishimura, Tomohito Okano, Masahiro Naito, et al.
World Journal of Clinical Cases|August 27, 2021
Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: A case reportTadashi Nishimura, Tomohito Okano, Masahiro Naito, et al.
Pharmaceuticals (Basel, Switzerland)|May 25, 2023
Prognostic Value of CXCL12 in Non-Small Cell Lung Cancer Patients Undergoing Tumor ResectionYurie Kogue, Hiroyasu Kobayashi, Yutaka Nakamura, et al.
Clinical Laboratory|February 28, 2007
Emergence of new variant rotavirus G3 among infants and children with acute gastroenteritis in Japan during 2003-2004Tung Gia Phan, Quang Duy Trinh, Pattara Khamrin, et al.
Journal of Medical Virology|May 25, 2006
Changing distribution of norovirus genotypes and genetic analysis of recombinant GIIb among infants and children with diarrhea in JapanTung Gia Phan, Toshimasa Kuroiwa, Kunio Kaneshi, et al.
Cancers|November 27, 2025
Real-World Comparative Study of Atezolizumab-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung CancerAyaka Ohiwa, Tadashi Nishimura, Tadashi Sakaguchi, et al.
Cancer Medicine|April 17, 2024
Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitorsTadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, et al.
Cancers|August 26, 2022
Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and ChemotherapyTadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Thoracic Cancer|February 15, 2021
Second-line therapy with first- or second-generation tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer patients with T790M-negative or unidentified mutationTadashi Nishimura, Tomohito Okano, Masahiro Naito, et al.
World Journal of Clinical Cases|August 27, 2021
Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: A case reportTadashi Nishimura, Tomohito Okano, Masahiro Naito, et al.
Pharmaceuticals (Basel, Switzerland)|May 25, 2023
Prognostic Value of CXCL12 in Non-Small Cell Lung Cancer Patients Undergoing Tumor ResectionYurie Kogue, Hiroyasu Kobayashi, Yutaka Nakamura, et al.
Clinical Laboratory|February 28, 2007
Emergence of new variant rotavirus G3 among infants and children with acute gastroenteritis in Japan during 2003-2004Tung Gia Phan, Quang Duy Trinh, Pattara Khamrin, et al.
Journal of Medical Virology|May 25, 2006
Changing distribution of norovirus genotypes and genetic analysis of recombinant GIIb among infants and children with diarrhea in JapanTung Gia Phan, Toshimasa Kuroiwa, Kunio Kaneshi, et al.
Cancers|November 27, 2025
Real-World Comparative Study of Atezolizumab-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung CancerAyaka Ohiwa, Tadashi Nishimura, Tadashi Sakaguchi, et al.
Cancer Medicine|April 17, 2024
Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitorsTadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, et al.
Cancers|August 26, 2022
Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and ChemotherapyTadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, et al.
Pageof 8